Skip to main content

Never miss an update!

Subscribe to receive weekly updates:

You have successfully subscribed. Something went wrong, please try again later
ProteoGenix
ProteoGenix
  • Herstellung von monoklonalen antikörpern

    Philippe Funfrock Philippe Funfrock August 13, 2018 6 min read

    [get_contact_slide form=”1279″ title=”Form. Antikörperherstellung”] [get_breadcrumbs class=”banner_breadcumb”] ProteoGenix hat XtenCHO entwickelt, das produktivste Expressionssystem zur Herstellung von transienten monoklonalen Antikörpern, das sogar die Leistung von ExpiCHO übertrifft. Aufbauend…

    Read more
  1. Budget Busters: How to Manage Costs and Resources in Antibody Development

    Read more
  2. From the first to the fifth generation of CAR-T cells

    Read more
  3. The structure of CAR-T cells

    Read more
  4. ADC linkers: Definition and examples

    Read more
  5. Robust methods for the detailed analysis of drug-to-antibody ratio (DAR) and drug load distribution

    Read more
ProteoGenix
Categories
  • Antibody production
  • Protein production
  • Peptide synthesis
  • Success stories
  • Unkategorisiert
About Us

©  ProteBlog 2025